Globlog: a blog about verbal identity

FDA Approves Zarxio, First Biosimilar Drug

Mar 09, 2015
New: Utrecht Centre of Excellence for Affordable Biotherapeutics

Mar 02, 2015
Actavis Plans Corporate Name Change to Allergan

Feb 18, 2015
Update on pharmaceutical brand name requirements in Canada

Feb 18, 2015
Putting our lives in their brands

Feb 06, 2015
Camargo Launches New Brand at GPhA as 505(b)(2)

Feb 04, 2015
FDA Tries to End Dispute Between Brand-Name and Generic Drug Makers

Dec 04, 2014
Record breaking new drug approvals

Jun 01, 2014
Making medicine emotional – Medical Marketing and Media

Jun 01, 2014
New drug approvals in ICH countries 2004-2013

Apr 19, 2014
How Big Pharma is “humanising” its brands

Feb 05, 2014
As biosims win nods in Europe and India, debate over naming rights …

Jan 29, 2014
Drug patent cliff to drive pharma firms into innovation, research

Jan 24, 2014
What’s in a name? Just about everything

Jan 19, 2014
Trade-name Drugs vs. Generic Drugs | Health Article Directory

Jan 13, 2014
Why Don’t You Trust Generic Drugs as Much as Brand Name Medicines?

Jan 13, 2014
Novartis and Merck: “Wanna Trade?” Companies Propose to Swap Businesses

Jan 10, 2014
A guide for international pharmaceutical communications: What do we really mean by brand value? (Part 1)

May 04, 2012
Double Trouble: Consumer awareness of look-alike names

Jan 01, 2010